Connect with us

Hi, what are you looking for?

Investing

Wegovy-Maker Novo Nordisk to Spend More Than $2 Billion Boosting Production in France

Published

By Elena Vardon

Pharmaceutical giant Novo Nordisk said it will invest more than 16 billion Danish kroner ($2.34 billion) in its French production site as it seeks to meet rising demand for its blockbuster obesity and diabetes treatments.

The Danish company, which makes the Wegovy obesity drug and diabetes drug Ozempic, said Thursday that the…

Master your money.

Subscribe to MarketWatch.

Get this article and all of MarketWatch.

Access from any device. Anywhere. Anytime.

Subscribe Now

Log In

Read the full article here

In this article:
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

Best Online Casinos in the World That Pay Real Money

Play at the best online casino for real money to benefit from awesome games, massive bonuses, secure banking, and much more. You have loads...

6 days ago

News

Explore Top Online Casinos in February 2025 – Dive into the World of Online Gaming!

Embark on an exhilarating journey for casino enthusiasts seeking seamless gaming experiences. Dive into a diverse array of classic and contemporary casino games effortlessly....

6 days ago

News

Психология ставок: как избежать эмоциональных решений

Ставки на спорт и азартные игры привлекают миллионы людей по всему миру. Однако многие из них не осознают, как сильно эмоции могут влиять на...

5 days ago

News

Pokerdom Casino Review February 2025

Pokerdom Casino is an online casino home to many of the best software providers, so players will have plenty to choose from when it...

5 days ago